Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
07 Octobre 2022 - 1:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or
15d-16
under the Securities Exchange Act of 1934
For the month of October, 2022
Commission File Number 001-39670
PURETECH HEALTH PLC
(Translation of registrants name into English)
6 Tide
Street, Suite 400
Boston, Massachusetts 02210
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On October 6, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the Company) issued a press release, as required by the UK City
Code on Takeovers and Mergers, regarding recent press speculation around a possible business combination proposal.
The press release is furnished
herewith as Exhibit 99.1 and is incorporated by reference herein.
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
PURETECH HEALTH PLC |
|
|
|
|
Date: October 7, 2022 |
|
|
|
By: |
|
/s/ Daphne Zohar |
|
|
|
|
|
|
Name: |
|
Daphne Zohar |
|
|
|
|
|
|
Title: |
|
Chief Executive Officer |
PureTech Health (NASDAQ:PRTC)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
PureTech Health (NASDAQ:PRTC)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024